TITLE

Influence of Prior Meningococcal C Polysaccharide Vaccination on the Response and Generation of Memory after Meningococcal C Conjugate Vaccination in Young Children

AUTHOR(S)
Borrow, Ray; Goldblatt, David; Andrews, Nick; Richmond, Peter; Southern, Joanna; Miller, Elizabeth
PUB. DATE
August 2001
SOURCE
Journal of Infectious Diseases;8/1/2001, Vol. 184 Issue 3, p377
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents a study which determined whether the immunological hyporesponsesiveness induced by meningococcal AC polysaccharide vaccine can be overcome by meningococcal C conjugate vaccine in children. Review of related literature; Characteristics of the participants; Materials and methods used; Results and discussion.
ACCESSION #
4927027

 

Related Articles

  • THE MEANING BEHIND MENINGITIS. McTaggart, Lynne // Ecologist;May2000, Vol. 30 Issue 3, p44 

    Criticizes the partnership between Great Britain's Department of Health and pharmaceutical company Wyeth for a mass vaccination campaign against the group C strain of meningococcal meningitis among children. Result of the tests conducted on anti-meningitis drug Meningitec; Causes of death among...

  • Group A and C meningococcal vaccines.  // Weekly Epidemiological Record;9/10/99, Vol. 74 Issue 36, p297 

    Examines the efficacy of group A and C meningococcal vaccines in controlling epidemics of meningococcal meningitis. Causes of meningococcal meningitis and septicemia; Use of vaccines in large-scale immunization programs; Number of mortality associated with meningococcal diseases.

  • Prevention of secondary cases of meningococcal disease in household contacts by vaccination. Greenwood, B.M.; Hassan-King, M.; Whittle, H.C. // British Medical Journal;5/20/1978, Vol. 1 Issue 6123, p1317 

    Household contacts of patients with group A meningococcal infection were vaccinated with either meningococcal vaccine or tetanus toxoid. Five of the 523 subjects who received tetanus toxoid developed meningococcal meningitis and another four probably had meningococcal disease. Only one possible...

  • Meningitis B vaccine looks promising. Sheldon, Tony // BMJ: British Medical Journal (International Edition);09/19/98, Vol. 317 Issue 7161, p770 

    Reveals that Dutch researchers believe that they have found an effective vaccine to combat group B meningococcal disease. Number of cases of bacterial meningitis in the Netherlands each year; Preliminary results of clinical trials with the vaccine; What most cases of meningococcal disease in...

  • Pipeline preview.  // Formulary;Nov2004, Vol. 39 Issue 11, p520 

    Updates on the U.S. Food & Drug Administration's actions on applications for drug approvals as of November 2004. Approval status of meningococcal polysaccharide diphtheria toxoid conjugate for vaccination against meningococcal disease; Drospirenone/estradiol for hormone replacement therapy;...

  • Low rate of adverse reactions for MeNZB. Topham-Kindley, Liane // New Zealand Doctor;9/21/2005, p3 

    Focuses on the general practice-based intensive meningococcal vaccine monitoring programme being conducted by the New Zealand Pharmacovigilance Centre. Significant events that have occurred during the programme; Number of reactions that have been reported through the spontaneous system; Purpose...

  • Timeline of Health Appointment.  // Bangor Metro;Aug2009, p66 

    The article offers preventive steps that women should take throughout their lifetimes to cope with their problems earlier. Women are suggested to discuss with their doctor the possibility of having meningococcal vaccine at the age of 18. They should have a clinical breast examination at least...

  • Vaccine for Meningococcal Meningitis Tested. Marwick, Charles // JAMA: Journal of the American Medical Association;10/16/91, Vol. 266 Issue 15, p2052 

    Reports on researchers at the U.S. National Institutes of Health's development of a vaccine that could immunize infants against meningococcal meningitis. Testing of the vaccine in mice; Lack of vaccines for meningococcal serotypes for infants; Ability of the vaccine to induce antibody to...

  • Human papillomavirus vaccine recombinant quadrivalent/meningococcal vaccine groups A C Y W-135 conjugate.  // Reactions Weekly;5/17/2008, Issue 1202, p18 

    The article describes two cases of the development of syncope following treatment of human papillomavirus vaccine (HPV) recombinant quadrivalent/meningococcal vaccine A C Y W-135 conjugate. It references a study by A. Sutherland et al, published in the May 2008 issue of the "Morbidity and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics